Migration contributes to flat HBV infection prevalence rate in US

August 12, 2015
Migration contributes to flat HBV infection prevalence rate in U.S.

(HealthDay)—The prevalence of chronic hepatitis B virus (HBV) infection has remained constant since 1999, according to a study published online Aug. 6 in Hepatology.

Henry Roberts, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues sought to determine the prevalence of HBV among non-institutionalized individuals aged 6 years and older. They examined the prevalence of antibody to hepatitis B core antigen (anti-HBc), hepatitis B surface antigen, and antibody to B surface antigen over three periods: 1988 to 1994, 1999 to 2009, and 2007 to 2012.

The researchers found that for 2007 to 2012, 3.9 percent had anti-HBc. Since 1999, the overall prevalence of chronic HBV infection remained constant at 0.3 percent; the prevalence among non-Hispanic blacks was two- to three-fold greater than that seen in the general population. During 2011 to 2012, an estimated 3.1 percent of non-Hispanic Asians were chronically infected with HBV. Since 1999, there was a 16 percent increase in the adjusted prevalence of vaccine-induced immunity, and there was an increase in the number of persons, mainly young, with serologic evidence of vaccine protection from HBV infection, from 57.8 to 68.5 million.

"Despite increasing immune protection in young persons vaccinated in infancy, an analysis of B prevalence in racial and ethnic populations indicates that during 2011 to 2012 there were 847,000 HBV infections (which included ~400,000 non-Hispanic Asians) in the non-institutionalized U.S. population," the authors write.

Explore further: Risk of hepatitis D higher among HIV infected and injection drug users

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Risk of hepatitis D higher among HIV infected and injection drug users

April 21, 2015
Researchers from Taiwan determined that individuals with human immunodeficiency virus (HIV) infection or those who inject illicit drugs have a higher risk of becoming infected with the hepatitis D virus (HDV) in that country. ...

Global expansion of hepatitis vaccination needed to progress hepatitis B elimination

April 23, 2015
Results revealed today at The International Liver Congress 2015 demonstrate current treatment and prevention programmes need to be scaled up in order to make elimination of hepatitis B virus (HBV) possible.

Taking immunosuppressives, anti-cancer drugs may reactivate Hepatitis B

February 5, 2015
Individuals previously infected with the hepatitis B virus (HBV) who receive chemotherapy or immunosuppressive treatment may be at risk of reactivating the disease according to a summary of report from the Emerging Trends ...

Hepatitis B immunization program in Taiwan associated with reduction in chronic liver disease deaths

September 3, 2013
"Hepatitis B virus (HBV) infection causes infant fulminant hepatitis (IFH), and chronic HBV infection may progress to chronic liver disease (CLD) and hepatocellular carcinoma (HCC). Taiwan launched a nationwide HBV immunization ...

Drug prevents passage of HBV during pregnancy

June 1, 2015
The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), according to a study in the June issue of Clinical Gastroenterology and Hepatology, the official clinical practice journal of the ...

Study quantifies prevalence of chronic HCV infection

March 4, 2014
(HealthDay)—The prevalence of hepatitis C virus (HCV) infection is about 1 percent, with 2.7 million U.S. residents estimated as having chronic HCV infection, according to a study published in the March 4 issue of the Annals ...

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.